Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 2, Pages e87704
Publisher
Public Library of Science (PLoS)
Online
2014-02-05
DOI
10.1371/journal.pone.0087704
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study
- (2013) Roy Eldor et al. PLoS One
- Insulin Detemir
- (2012) Gillian M. Keating DRUGS
- Characterizing the Impact of Renal Impairment on the Clinical Pharmacology of Biologics
- (2012) Bernd Meibohm et al. JOURNAL OF CLINICAL PHARMACOLOGY
- GLP2-2G-XTEN: A Pharmaceutical Protein with Improved Serum Half-Life and Efficacy in a Rat Crohn’s Disease Model
- (2012) Susan E. Alters et al. PLoS One
- Parathyroid hormone analogues in the treatment of osteoporosis
- (2011) Marius E. Kraenzlin et al. Nature Reviews Endocrinology
- Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing
- (2010) Mark Fineman et al. CLINICAL PHARMACOKINETICS
- Oral salmon calcitonin – pharmacology in osteoporosis
- (2010) Kim Henriksen et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Liraglutide: the therapeutic promise from animal models
- (2010) L. B. Knudsen INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain
- (2010) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fc-Based Cytokines
- (2009) Jalal A Jazayeri et al. BIODRUGS
- Short bowel syndrome: the role of GLP-2 on improving outcome
- (2009) Katharina Wallis et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics
- (2009) Jan Terje Andersen et al. Drug Metabolism and Pharmacokinetics
- A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
- (2009) Volker Schellenberger et al. NATURE BIOTECHNOLOGY
- Engineering of a femtomolar affinity binding protein to human serum albumin
- (2008) A. Jonsson et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Mutational analysis of the interaction between albumin-binding domain from streptococcal protein G and human serum albumin
- (2002) Martin Linhult et al. PROTEIN SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started